Combating T-cell Dysfunction in Cutaneous Squamous Cell Carcinoma: Integrating Checkpoint Inhibitors into Clinical Practice and Managing Adverse Events

REGISTER NOW!
Already Registered?
SIGN IN

WEBCAST DATE

Sunday, January 26, 2020

11:15 AM Eastern    10:15 AM Central    09:15 AM Mountain    08:15 AM Pacific    06:15 AM Hawaii

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Describe the mechanism of action of checkpoint inhibitors and the impact of high tumor mutational burden and tumor-infiltrating lymphocytes on treatment outcomes
• Identify patients with cSCC who are at high-risk of recurrence or metastasis and apply recommendations from current treatment guidelines to minimize risk
• Review clinical trial data supporting the use of checkpoint inhibitors in the management of cutaneous squamous cell carcinoma
• Recognize and manage immune-related adverse events (irAEs) associated with checkpoint inhibitors

FACULTY

Todd E. Schlesinger, MD, FAAD
Director, Dermatology and Laser Center of Charleston
Clinical Research Center of the Carolinas
Clinical Instructor, University at Buffalo Department of Dermatology
Affiliate Assistant Professor, Medical University of South Carolina, Department of Family Medicine
Charleston, SC

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.